{
    "clinical_study": {
        "@rank": "26714", 
        "arm_group": [
            {
                "arm_group_label": "mesenchymal cell and fibroblast transplantaion", 
                "arm_group_type": "Active Comparator", 
                "description": "The patients with crohn's disease who underwent mesenchymal cell and fibroblast  injection."
            }, 
            {
                "arm_group_label": "mesenchymal cell transplantaion", 
                "arm_group_type": "Active Comparator", 
                "description": "The patients with Crohn's disease who underwent mesenchymal cell transplantation."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is a prospective, randomized, parallel, phase 1 trial to assess the safety and\n      feasibility of the transplantation of bone marrow derived mesenchymal stem cells (MSCs) in\n      fistulizing Crohn's disease."
        }, 
        "brief_title": "Transplantation of Bone Marrow Mesenchymal Stem Cell in Crohn's Disease", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Crohn's Disease", 
        "condition_browse": {
            "mesh_term": "Crohn Disease"
        }, 
        "detailed_description": {
            "textblock": "In this study all eligible patients were randomly allocated into two study groups by a\n      permuted block randomization method: group A receives only autologous MSCs suspended in\n      fibrin glue, group B receives autologous MSCs+ Fibroblasts. Both groups receive 4 injections\n      inside the wall and lumen of the fistula. Injections will be repeated every month."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  1- Poor response to routine treatments in refractory Crohn's disease with fistula.\n\n             2- CDAI>220 3- Age 18 to 60 years 4- GFR>30, Cr<2 5- The presence of perinea fistula.\n\n        Exclusion Criteria:\n\n          -  pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01874015", 
            "org_study_id": "Royan-GI-003"
        }, 
        "intervention": [
            {
                "arm_group_label": "mesenchymal cell transplantaion", 
                "description": "Mesenchymal cell transplantation in patients with Crohn's disease.", 
                "intervention_name": "mesenchymal cell transplantation", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "mesenchymal cell and fibroblast transplantaion", 
                "description": "Transplantation of mesenchymal cell and fibroblast in patients with crohn's disease.", 
                "intervention_name": "mesenchymal cell and fibroblast injection", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Crohn's disease", 
            "mesenchymal stem cell", 
            "fistula"
        ], 
        "lastchanged_date": "May 10, 2014", 
        "link": {
            "url": "http://Royaninstitute.org"
        }, 
        "location": {
            "contact": {
                "last_name": "Nasser Aghdami, MD,PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Tehran", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Royan Institute"
            }, 
            "investigator": [
                {
                    "last_name": "Massoud Vosough, MD,PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "vagihe azimian, MSc", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Transplantation of Bone Marrow Mesenchymal Stem Cell in Moderate to Severe Fistulizing Crohn's Disease", 
        "overall_contact": {
            "email": "nasser.aghdami@royaninstitute.org", 
            "last_name": "Nasser Aghdami, MD,PhD", 
            "phone": "+9823562000", 
            "phone_ext": "504"
        }, 
        "overall_contact_backup": {
            "email": "Leara91@gmail.com", 
            "last_name": "Leila Arab, MD", 
            "phone": "+9823562000", 
            "phone_ext": "414"
        }, 
        "overall_official": [
            {
                "affiliation": "Head of Royan Institute", 
                "last_name": "Hamid Gourabi, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Head of Royan department of degenerative medicine,Head of Royan celltherapy center", 
                "last_name": "Nasser Aghdami, MD,PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "TUMS DDRI", 
                "last_name": "Mahdi Mohammad Nejhad, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Iran: Ethics Committee", 
                "Iran: Ministry of Health"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluation the fistula closure after mesenchymal cell transplantation in patients with crohn's disease.", 
            "measure": "fistula closure", 
            "safety_issue": "Yes", 
            "time_frame": "4months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01874015"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Evaluation the decrease of CDAI after mesenchymal cell transplantation.", 
            "measure": "CDAI", 
            "safety_issue": "Yes", 
            "time_frame": "4months"
        }, 
        "source": "Royan Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Royan Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}